Exercise Intervention for Cardiometabolic Health
(PACE Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team.
What data supports the effectiveness of the treatment Exercise Intervention for Cardiometabolic Health?
Research shows that exercise training can improve markers of exercise capacity, which is linked to better quality of life, especially for those with limited exercise capacity due to health issues. Additionally, exercise therapy has been shown to improve cardiometabolic risk factors and overall health outcomes in patients with cardiometabolic conditions.12345
Is exercise intervention generally safe for humans?
Exercise interventions are generally safe for humans, with few serious adverse events reported. Minor issues, like muscle injuries, can occur, especially in sedentary or older individuals, but starting slowly and gradually increasing intensity helps minimize risks. High-intensity exercise may have a slightly higher risk, so it should be done with caution and under supervision, especially for those with heart or metabolic conditions.678910
How does the exercise intervention treatment differ from other treatments for cardiometabolic health?
The exercise intervention treatment is unique because it focuses on improving cardiometabolic health through physical activity, which can enhance body composition, aerobic capacity, and blood glucose levels without the use of medication. Unlike traditional drug treatments, this approach leverages the body's natural responses to exercise, offering a non-invasive and holistic way to manage cardiometabolic conditions.511121314
What is the purpose of this trial?
The goal of this study is to understand the interaction between the circadian system and physical activity.Participants will:* complete 2 inpatient stays* perform moderate exercise* be provided with identical meals* have frequent blood draws* provide urine and saliva samples
Research Team
Jingyi Qian, PhD
Principal Investigator
Brigham and Women's Hospital
Eligibility Criteria
This trial is for healthy adults aged 20-45 with a BMI of 20-34.9, without any serious health issues like heart disease or cancer. Participants must be willing to follow the study's rules, including staying in the hospital and doing moderate exercise.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Inpatient Stay 1
Participants complete the first inpatient stay, perform moderate exercise, are provided with identical meals, and have frequent blood draws
Inpatient Stay 2
Participants complete the second inpatient stay, perform moderate exercise, are provided with identical meals, and have frequent blood draws
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Exercise intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brigham and Women's Hospital
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator